Biotechnology & Life Sciences Global On demand · 24-48h

Global 2D Single-use Bioprocessing Bags Market Strategic Research Report

Global 2D Single-use Bioprocessing Bags Market Strategic Res…
$3,500 USD
Market Research Reports
Strategic Research Report
Global 2D Single-use Bioprocessing Bags Market
$5052025
4.7%CAGR
2032Forecast
Market Research Reports · Global
Market Research Reports Intelligence Series

By Type: ≤100L, 100-500L, ≥500L

By Application: Biopharmaceutical, Cell Therapy, Vaccine Manufacturing, Genetic Engineering, Others

Regional Forecast: Asia Pacific, Latin America, MEA, Europe, North America

Key Players: Entegris, Thermo Fisher, Avantor, Sartorius, Corning, Cytiva, Saint-Gobain Life Sciences, Kühner, CellBios, Meissner, Cobetter, Nupore, Vonco, TECNIC, CLARIPURE, D&D Filtration, Zhejiang JYSS Bio-Engineering, Shanghai Lepure Biotech, Dongfulong Life Technology, Shanghai Duoning Biotechnology, Truking Technology, Applitech Biological Technology, Shanghai Baigaole Biotechnology

Region: Global
Formats: PDF, Excel, Word & PowerPoint
Base year: 2025 · forecast to 2032
Length: 155 pages
Market size 2025
$505
Million USD
Forecast CAGR
4.7%
2025-2032
Forecast 2032
$696.5
Projected
영역들
5
Asia Pacific · Latin America · MEA · Europe · North America

개요

Scope of the Report

The global 2D Single-use Bioprocessing Bags market size is predicted to grow from US$ 505 million in 2025 to US$ 695 million in 2032; it is expected to grow at a CAGR of 4.7% from 2026 to 2032.

In 2025, global 2D Single-use Bioprocessing Bags production reached approximately 1,670 k units,with an average global market price of around US$ 310 per unit, and a gross profit margin of approximately 10%-30%. The 2D Single-use Bioprocessing Bags are planar flexible containers fabricated from multilayer polymer films via thermal sealing, designed for biological processes requiring low-shear suspension culture or adsorption separation. These bags feature aseptic sealing, single-use disposability, and rapid deployment, effectively minimizing contamination risks while enhancing operational efficiency.

The 2D single-use bioprocessing bag market is growing as biopharma facilities expand flexible, closed fluid handling for buffers, media, and intermediate holds. Compared with 3D bags, 2D bags are widely used across many steps due to simpler geometry, easier handling, and broad compatibility with totes and mixing stations. Demand is driven by multi-product operations, CDMO growth, and increased use of single-use systems in vaccines, biologics, and cell and gene therapy. Buyers prioritize low extractables/leachables, seal integrity, connector reliability, and consistent quality documentation. Trends include improved multilayer films with better barrier and toughness, standardized aseptic connector interfaces, and more automation in bag handling and filling. Constraints include supply volatility in medical-grade films, requalification workload for material changes, and strict particulate and leak risk management. Overall, growth is strong, with value concentrating in validated film systems, robust sealing processes, and secure supply assurance.

Key Questions Addressed in this Report

What is the 10-year outlook for the global 2D Single-use Bioprocessing Bags market?

What factors are driving 2D Single-use Bioprocessing Bags market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do 2D Single-use Bioprocessing Bags market opportunities vary by end market size?

How does 2D Single-use Bioprocessing Bags break out by Type, by Application?

This report presents a comprehensive overview of the global 2D Single-use Bioprocessing Bags market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

  • ≤100L
  • 100-500L
  • ≥500L

Segment by Structure

  • Single Layer
  • Multi Layer

Segment by Action

  • Storage
  • Transportation

Segment by Application

  • Biopharmaceutical
  • Cell Therapy
  • Vaccine Manufacturing
  • Genetic Engineering
  • Others

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global 2D Single-use Bioprocessing Bags market:

  • Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
  • Distributors, channel partners and end users in Biopharmaceutical, Cell Therapy, Vaccine Manufacturing evaluating demand and sourcing options
  • Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
  • Government agencies, industry associations and research institutions tracking industry developments and policy impact

Market snapshot

Global 2D Single-use Bioprocessing Bags Market Strategic Research Report snapshot, 2025–2032

Source: Market Research Reports
Market size CAGR 4.7%
Regional growth momentum
Market share by segment
Key metrics
Base value
$505
2025
Forecast
$696.5
2032
CAGR
4.7%
2025–2032
영역들
5
global
Key companies
EntegrisThermo FisherAvantorSartoriusCorningCytivaSaint-Gobain Life SciencesKühner
© MarketResearchReports.comDisclaimer: The actual data may vary in the final report which undergoes verification check post order confirmation.

Segments covered in this report

By Type
≤100L100-500L≥500L
By Application
BiopharmaceuticalCell TherapyVaccine ManufacturingGenetic EngineeringOthers

Table of contents

Click a chapter to expand
01Executive Summary
02Industry Overview & Forecast
  • 2.1.1 Market Definition and Scope
  • 2.1.2 Market Size and Growth Forecast
  • 2.1.3 Volume Analysis
  • 2.1.4 Segment Outlook by Type
  • 2.1.5 Segment Outlook by Application
  • 2.1.6 Regional Outlook
  • 2.1.7 Structural Developments Shaping the Forecast
  • 2.1.8 Forecast Risks and Sensitivities
03Market Segmentation by Type
  • 3.1 Market Segmentation by Type
  • 3.1.1 Market by Type Overview
  • 3.1.2 ≤100L
  • 3.1.3 100-500L
  • 3.1.4 ≥500L
  • 3.1.5 Volume Analysis
04Market Segmentation by Application
  • 4.1 Market Segmentation by Application
  • 4.1.1 Market by Application Overview
  • 4.1.2 Biopharmaceutical
  • 4.1.3 Cell Therapy
  • 4.1.4 Vaccine Manufacturing
  • 4.1.5 Genetic Engineering
  • 4.1.6 Others
  • 4.1.7 Volume Analysis
05Regional Market Forecast
  • Asia Pacific
  • North America
  • Europe
  • Middle East & Africa
  • Latin America
06Country-Level Market Forecast
  • 6.1 Asia Pacific
  • 6.1.1 China
  • 6.1.2 Japan
  • 6.1.3 Korea
  • 6.1.4 Southeast Asia
  • 6.1.5 India
  • 6.1.6 Australia
  • 6.1.7 Rest of Asia Pacific
  • 6.2 North America
  • 6.2.1 United States
  • 6.2.2 Canada
  • 6.2.3 Mexico
  • 6.2.4 Rest of North America
  • 6.3 Europe
  • 6.3.1 Germany
  • 6.3.2 France
  • 6.3.3 UK
  • 6.3.4 Italy
  • 6.3.5 Russia
  • 6.3.6 Rest of Europe
  • 6.4 Middle East & Africa
  • 6.4.1 Egypt
  • 6.4.2 South Africa
  • 6.4.3 Israel
  • 6.4.4 Turkey
  • 6.4.5 GCC Countries
  • 6.4.6 Rest of Middle East & Africa
  • 6.5 Latin America
  • 6.5.1 Brazil
  • 6.5.2 Rest of Latin America
07Growth Drivers & Inhibitors
  • 7.1 Growth Drivers & Inhibitors
  • 7.1.1 Section Overview
  • 7.1.2 Growth Drivers
  • 7.1.3 Growth Inhibitors
  • 7.1.4 Driver and Inhibitor Impact Assessment
  • 7.1.5 Analyst Perspective
08Key Company Profiles
  • 8.1 Entegris
  • 8.1.1 Company Overview
  • 8.1.2 Key Products & Segments
  • 8.1.3 Financial Performance (2023–2025)
  • 8.1.4 Business Strategy
  • 8.1.5 SWOT Analysis
  • 8.1.6 Strategic Implications (2026–2032)
  • 8.2 Thermo Fisher
  • 8.2.1 Company Overview
  • 8.2.2 Key Products & Segments
  • 8.2.3 Financial Performance (2023–2025)
  • 8.2.4 Business Strategy
  • 8.2.5 SWOT Analysis
  • 8.2.6 Strategic Implications (2026–2032)
  • 8.3 Avantor
  • 8.3.1 Company Overview
  • 8.3.2 Key Products & Segments
  • 8.3.3 Financial Performance (2023–2025)
  • 8.3.4 Business Strategy
  • 8.3.5 SWOT Analysis
  • 8.3.6 Strategic Implications (2026–2032)
  • 8.4 Sartorius
  • 8.4.1 Company Overview
  • 8.4.2 Key Products & Segments
  • 8.4.3 Financial Performance (2023–2025)
  • 8.4.4 Business Strategy
  • 8.4.5 SWOT Analysis
  • 8.4.6 Strategic Implications (2026–2032)
  • 8.5 Corning
  • 8.5.1 Company Overview
  • 8.5.2 Key Products & Segments
  • 8.5.3 Financial Performance (2023–2025)
  • 8.5.4 Business Strategy
  • 8.5.5 SWOT Analysis
  • 8.5.6 Strategic Implications (2026–2032)
  • 8.6 Cytiva
  • 8.6.1 Company Overview
  • 8.6.2 Key Products & Segments
  • 8.6.3 Financial Performance (2023–2025)
  • 8.6.4 Business Strategy
  • 8.6.5 SWOT Analysis
  • 8.6.6 Strategic Implications (2026–2032)
  • 8.7 Saint-Gobain Life Sciences
  • 8.7.1 Company Overview
  • 8.7.2 Key Products & Segments
  • 8.7.3 Financial Performance (2023–2025)
  • 8.7.4 Business Strategy
  • 8.7.5 SWOT Analysis
  • 8.7.6 Strategic Implications (2026–2032)
  • 8.8 Kühner
  • 8.8.1 Company Overview
  • 8.8.2 Key Products & Segments
  • 8.8.3 Financial Performance (2023–2025)
  • 8.8.4 Business Strategy
  • 8.8.5 SWOT Analysis
  • 8.8.6 Strategic Implications (2026–2032)
  • 8.9 CellBios
  • 8.9.1 Company Overview
  • 8.9.2 Key Products & Segments
  • 8.9.3 Financial Performance (2023–2025)
  • 8.9.4 Business Strategy
  • 8.9.5 SWOT Analysis
  • 8.9.6 Strategic Implications (2026–2032)
  • 8.10 Meissner
  • 8.10.1 Company Overview
  • 8.10.2 Key Products & Segments
  • 8.10.3 Financial Performance (2023–2025)
  • 8.10.4 Business Strategy
  • 8.10.5 SWOT Analysis
  • 8.10.6 Strategic Implications (2026–2032)
  • 8.11 Cobetter
  • 8.11.1 Company Overview
  • 8.11.2 Key Products & Segments
  • 8.11.3 Financial Performance (2023–2025)
  • 8.11.4 Business Strategy
  • 8.11.5 SWOT Analysis
  • 8.11.6 Strategic Implications (2026–2032)
  • 8.12 Nupore
  • 8.12.1 Company Overview
  • 8.12.2 Key Products & Segments
  • 8.12.3 Financial Performance (2023–2025)
  • 8.12.4 Business Strategy
  • 8.12.5 SWOT Analysis
  • 8.12.6 Strategic Implications (2026–2032)
  • 8.13 Vonco
  • 8.13.1 Company Overview
  • 8.13.2 Key Products & Segments
  • 8.13.3 Financial Performance (2023–2025)
  • 8.13.4 Business Strategy
  • 8.13.5 SWOT Analysis
  • 8.13.6 Strategic Implications (2026–2032)
  • 8.14 TECNIC
  • 8.14.1 Company Overview
  • 8.14.2 Key Products & Segments
  • 8.14.3 Financial Performance (2023–2025)
  • 8.14.4 Business Strategy
  • 8.14.5 SWOT Analysis
  • 8.14.6 Strategic Implications (2026–2032)
  • 8.15 CLARIPURE
  • 8.15.1 Company Overview
  • 8.15.2 Key Products & Segments
  • 8.15.3 Financial Performance (2023–2025)
  • 8.15.4 Business Strategy
  • 8.15.5 SWOT Analysis
  • 8.15.6 Strategic Implications (2026–2032)
  • 8.16 D&D Filtration
  • 8.16.1 Company Overview
  • 8.16.2 Key Products & Segments
  • 8.16.3 Financial Performance (2023–2025)
  • 8.16.4 Business Strategy
  • 8.16.5 SWOT Analysis
  • 8.16.6 Strategic Implications (2026–2032)
  • 8.17 Zhejiang JYSS Bio-Engineering
  • 8.17.1 Company Overview
  • 8.17.2 Key Products & Segments
  • 8.17.3 Financial Performance (2023–2025)
  • 8.17.4 Business Strategy
  • 8.17.5 SWOT Analysis
  • 8.17.6 Strategic Implications (2026–2032)
  • 8.18 Shanghai Lepure Biotech
  • 8.18.1 Company Overview
  • 8.18.2 Key Products & Segments
  • 8.18.3 Financial Performance (2023–2025)
  • 8.18.4 Business Strategy
  • 8.18.5 SWOT Analysis
  • 8.18.6 Strategic Implications (2026–2032)
  • 8.19 Dongfulong Life Technology
  • 8.19.1 Company Overview
  • 8.19.2 Key Products & Segments
  • 8.19.3 Financial Performance (2023–2025)
  • 8.19.4 Business Strategy
  • 8.19.5 SWOT Analysis
  • 8.19.6 Strategic Implications (2026–2032)
  • 8.20 Shanghai Duoning Biotechnology
  • 8.20.1 Company Overview
  • 8.20.2 Key Products & Segments
  • 8.20.3 Financial Performance (2023–2025)
  • 8.20.4 Business Strategy
  • 8.20.5 SWOT Analysis
  • 8.20.6 Strategic Implications (2026–2032)
  • 8.21 Truking Technology
  • 8.21.1 Company Overview
  • 8.21.2 Key Products & Segments
  • 8.21.3 Financial Performance (2023–2025)
  • 8.21.4 Business Strategy
  • 8.21.5 SWOT Analysis
  • 8.21.6 Strategic Implications (2026–2032)
  • 8.22 Applitech Biological Technology
  • 8.22.1 Company Overview
  • 8.22.2 Key Products & Segments
  • 8.22.3 Financial Performance (2023–2025)
  • 8.22.4 Business Strategy
  • 8.22.5 SWOT Analysis
  • 8.22.6 Strategic Implications (2026–2032)
  • 8.23 Shanghai Baigaole Biotechnology
  • 8.23.1 Company Overview
  • 8.23.2 Key Products & Segments
  • 8.23.3 Financial Performance (2023–2025)
  • 8.23.4 Business Strategy
  • 8.23.5 SWOT Analysis
  • 8.23.6 Strategic Implications (2026–2032)
09Competitive Landscape
  • 9.1 Competitive Landscape Overview
  • 9.2 Competitive Intensity Assessment
  • 9.3 Key Player Strategies & Positioning
  • 9.4 Competitive Dynamics & Strategic Outlook
  • 9.4.1 Emerging Competitive Threats
  • 9.4.2 Consolidation vs. Fragmentation Outlook
  • 9.4.3 Competitive Response Matrix
  • 9.4.4 Strategic Recommendations, 2026–2032
10Porter's Five Forces Analysis
  • 10.1 Threat of New Entrants
  • 10.2 Bargaining Power of Buyers
  • 10.3 Bargaining Power of Suppliers
  • 10.4 Threat of Substitutes
  • 10.5 Competitive Rivalry
11PESTLE Analysis
  • 11.1 Political
  • 11.2 Economic
  • 11.3 Social and Demographic
  • 11.4 Technological
  • 11.5 Legal and Regulatory
  • 11.6 Environmental
  • 11.7 Strategic Implications of the PESTLE Assessment
12SWOT Analysis
13Future Trends & Outlook
  • 13.1 Future Trends & Outlook
  • 13.1.1 Trend Summary and Commercial Maturity Assessment
  • 13.1.2 Technology and Innovation Trends
  • 13.1.3 Long-Term Market Outlook
  • 13.1.4 Investment & M&A Activity Outlook
  • 13.1.5 Overall Outlook Assessment

Frequently asked questions

What is the current global 2D Single-use Bioprocessing Bags market size?
The global 2D Single-use Bioprocessing Bags market is estimated at US$ 505 million in 2025 (base year) and is projected to reach US$ 695 million by 2032.
What growth rate is expected for the 2D Single-use Bioprocessing Bags market through 2032?
The market is expected to grow at a CAGR of 4.7% from 2026 to 2032, expanding from US$ 505 million in 2025 to US$ 695 million in 2032, roughly 1.4 times its base-year value.
How is 2D Single-use Bioprocessing Bags defined?
In 2025, global 2D Single-use Bioprocessing Bags production reached approximately 1,670 k units,with an average global market price of around US$ 310 per unit, and a gross profit margin of approximately 10%-30%. The 2D Single-use Bioprocessing Bags are planar flexible containers fabricated from multilayer polymer films via thermal sealing, designed for biological processes requiring low-shear suspension culture or adsorption separation.
How is the 2D Single-use Bioprocessing Bags market segmented by type?
By type, the market is segmented into ≤100L, 100-500L and ≥500L.
What are the key applications of 2D Single-use Bioprocessing Bags?
Key applications covered include Biopharmaceutical, Cell Therapy, Vaccine Manufacturing, Genetic Engineering and Others.
Which companies are profiled in the 2D Single-use Bioprocessing Bags market report?
Key players profiled include Entegris, Thermo Fisher, Avantor, Sartorius, Corning, Cytiva, Saint-Gobain Life Sciences and Kühner, among 23 companies covered in total.
What geographies does the 2D Single-use Bioprocessing Bags market analysis include?
The market is analysed across Asia Pacific, North America, Europe, Middle East & Africa and Latin America, with 20 country-level markets including China, Japan, United States, Canada, Germany, France, Egypt and South Africa.
What are the key demand drivers for 2D Single-use Bioprocessing Bags?
Demand is driven by multi-product operations, CDMO growth, and increased use of single-use systems in vaccines, biologics, and cell and gene therapy.
What are the main risks and barriers in the 2D Single-use Bioprocessing Bags market?
Trends include improved multilayer films with better barrier and toughness, standardized aseptic connector interfaces, and more automation in bag handling and filling.
Who should buy the 2D Single-use Bioprocessing Bags market report?
The report is intended for manufacturers and solution providers, distributors and end users in Biopharmaceutical, Cell Therapy and Vaccine Manufacturing, investors and consultants, and government or industry bodies who need market size, segmentation, competitive and regional data for the 2D Single-use Bioprocessing Bags market.
What license options are available for this report?
The report is available as a Single User License (US$ 3,500, one named user), a Site License (US$ 5,250, up to 10 users) and a Global / Corporate License (US$ 7,000, unlimited users), all delivered in PDF format.

Research Methodology

All MarketResearchReports.com strategic research reports follow a rigorous, multi-stage methodology combining AI-assisted data synthesis with expert analyst validation.

01
Secondary Research & Data Aggregation

Systematic collection from 500+ verified sources including SEC filings, industry databases (Bloomberg, Statista, OECD), regulatory filings, trade publications, patent databases, and company annual reports. AI-assisted extraction identifies relevant data points across 10,000+ documents per report.

02
Market Sizing — Bottom-Up & Top-Down

Dual-validation approach: bottom-up sizing aggregates segment-level production, consumption, and trade data; top-down sizing cross-validates against macroeconomic indicators and total addressable market estimates. Discrepancies >5% trigger analyst review.

03
Competitive Intelligence

Company profiles built from public financial disclosures, product launches, M&A activity, job postings (as capability proxies), and supply chain mapping. Market share estimates triangulated across revenue, capacity, and shipment data.

04
Demand Forecasting

CAGR projections use time-series regression on 5-10 years of historical data, adjusted for identified demand drivers (technology adoption curves, regulatory catalysts, demographic shifts) and demand inhibitors (cost barriers, substitution risk). Scenario modeling covers base, optimistic, and conservative cases.

05
Analyst Validation & Quality Assurance

All quantitative outputs reviewed by a domain-specialist analyst before publication. Data triangulation requires minimum 3 independent sources for every key figure. Reports undergo a structured peer review against our 47-point quality checklist covering methodology, data citations, logical consistency, and formatting standards.

06
Continuous Updates

On-demand reports are generated at time of purchase, incorporating the most recent available data. Static reports are republished when underlying market conditions shift by >10% from baseline assumptions. Purchasers receive update notifications for 12 months.

Select a license
from US$3,500.00
Report License Type
Optional add-ons
On demand · delivered within 24-48 hours
Secure checkout · SSL encrypted
License terms included
Post-purchase analyst support
Custom research

Need a customized version?

Get country-, segment- or company-specific intelligence tailored to your exact requirements.

Request custom research →
Talk to a research advisor USA: +1-302-703-9904 India: +91-8762746600
Trusted by

Leading Brands in This Industry

Logos are trademarks of their respective owners and indicate a verified past business relationship, not a current partnership or endorsement.